Database Query Results : , , PDT+

PDT+, PDT+cells: Click to Expand ⟱
Source:
Type:
PD-1+Tim-3+terminal CD8+ T cells (PDT+)

-In several studies across different malignancies, high frequencies of PD-1⁺Tim-3⁺ terminal CD8⁺ T cells have been associated with advanced disease stages or an immunosuppressive tumor microenvironment.
-Their accumulation may correlate with a poorer prognosis, as it reflects chronic immune stimulation and subsequent T cell dysfunction.
Scientific Papers found: Click to Expand⟱
2504- H2,    Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer
- Trial, Lung, NA
CD8+↑, OS↑, eff↝, CoQ10↑, PDT+↓, PGC-1α↑, Dose↝, *toxicity∅,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

CoQ10↑, 1,  

Mitochondria & Bioenergetics ⓘ

PGC-1α↑, 1,  

Immune & Inflammatory Signaling ⓘ

PDT+↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   eff↝, 1,  

Functional Outcomes ⓘ

OS↑, 1,  

Infection & Microbiome ⓘ

CD8+↑, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Functional Outcomes ⓘ

toxicity∅, 1,  
Total Targets: 1

Scientific Paper Hit Count for: PDT+, PDT+cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1316  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page